Literature DB >> 22367068

Compliance status of product labels to the international code on marketing of breast milk substitutes.

Ahmet Ergin1, Celile Hatipoğlu, Ali Ihsan Bozkurt, Aslı Erdoğan, Serdar Güler, Gülberat Ince, Nuran Kavurgacı, Ahmet Oz, Mustafa K Yeniay.   

Abstract

The aim of this study was to determine the compliance status of product labels regarding Article 9 of the International Code on Marketing of Breast-milk Substitutes (the Code) in Denizli province, Turkey. A cross-sectional study design was employed to determine the compliance status. The product labels were obtained from a convenience sample of five supermarkets, one store and 5 pharmacies in the City centre and district of Honaz. Using a data collection form prepared by previously published studies, data were collected between July 26, 2010 and August 06, 2010. Data collection form included 13 criteria. In addition, we checked the boxes for the availability of a Turkish written label. Forty product labels of 7 companies were reached and evaluated. These products consisted of 83.0% of the products marketed by these companies in Turkey. Thirty seven (92.5%) of the labels violated Article 9 of the Code in terms of one or more criteria. Thirty four (85.0%) of the labels had photos or pictures idealizing the use of infant formula. Nine (22.5%) had a photo, a picture or any representation of an infant, and five (12.5%) had text which idealize the use of infant formula or discouraging breastfeeding. Eight (20%) did not state that breastfeeding is the best. Four (10%) had a term such as 'similar to breast milk or human milk'. In conclusion, the majority of the product labels of breast milk substitutes marketed in our country violate the Code. It is appropriate that the Turkish Ministry of Health, medical organizations, companies, and NGOs work more actively to increase awareness of this issue.

Entities:  

Mesh:

Year:  2013        PMID: 22367068     DOI: 10.1007/s10995-012-0971-5

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  3 in total

1.  Breastfeeding and the use of human milk. American Academy of Pediatrics. Work Group on Breastfeeding.

Authors: 
Journal:  Pediatrics       Date:  1997-12       Impact factor: 7.124

2.  Monitoring compliance with the International Code of Marketing of Breastmilk Substitutes in west Africa: multisite cross sectional survey in Togo and Burkina Faso.

Authors:  Victor M Aguayo; Jay S Ross; Souleyman Kanon; Andre N Ouedraogo
Journal:  BMJ       Date:  2003-01-18

3.  Formula labeling violations to the WHO Code: a quantitative and qualitative analysis.

Authors:  Ana M Parrilla-Rodríguez; José J Gorrín-Peralta
Journal:  P R Health Sci J       Date:  2008-03       Impact factor: 0.705

  3 in total
  4 in total

1.  Readability and Content Characteristics of Powdered Infant Formula Instructions in the United States.

Authors:  Lorraine S Wallace; Patricia Fine Rosenstein; Noga Gal
Journal:  Matern Child Health J       Date:  2016-04

2.  Violations of the International Code of Marketing of Breast-milk Substitutes in Mexico.

Authors:  Sonia Hernández-Cordero; Ana Lilia Lozada-Tequeanes; Teresa Shamah-Levy; Chessa Lutter; Teresita González de Cosío; Pedro Saturno-Hernández; Juan Rivera Dommarco; Laurence Grummer-Strawn
Journal:  Matern Child Nutr       Date:  2018-09-28       Impact factor: 3.092

3.  World Health Assembly agendas and trends of international health issues for the last 43 years: analysis of World Health Assembly agendas between 1970 and 2012.

Authors:  Tomomi Kitamura; Hiromi Obara; Yoshihiro Takashima; Kenzo Takahashi; Kimiko Inaoka; Mari Nagai; Hiroyoshi Endo; Masamine Jimba; Yasuo Sugiura
Journal:  Health Policy       Date:  2013-01-05       Impact factor: 2.980

4.  Violations of International Code of Breast-milk Substitutes (BMS) in commercial settings and media in Bangladesh.

Authors:  Sifat P Sheikh; Syeda M Akter; Faugia I Anne; Santhia Ireen; Jessica Escobar-Alegria; Kirsten Kappos; Deborah Ash; Sabrina Rasheed
Journal:  Matern Child Nutr       Date:  2022-03-21       Impact factor: 3.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.